BioWorld-International-2003-08-20
Chromosomal Breaks Could Hold Clues To Cancer Targets
Xenova Adding To Pipeline Via £8.5M KS Biomedix Acquisition
LONDON - Consolidation continues in the UK as Xenova Group plc announced an agreed-to £8.48 million (US$13.5 million) all-share takeover offer for KS Biomedix plc (KSB). (BioWorld International)

